Top 10 Chemical Stocks For 2016

Top 10 Chemical Stocks For 2016: Cereplast Inc (CERPQ)

Cereplast, Inc. (Cereplast), incorporated on September 29, 2001, is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. The Company primarily conducts its operations through product families, such as Cereplast Compostables resins, Cereplast Hybrid Resins and Cereplast Algae Plastic resins. In October 2011, the Company purchased a manufacturing plant in Assisi (Cannara).

Cereplast Compostables resins are compostable and bio-based, ecologically sound substitutes for petroleum-based plastics targeting primarily compostable bags, single-use food service products and packaging applications. The Compa ny offers 13 commercial grades of Compostable resins in this product line. Cereplast Sustainables resins are partially or fully bio-based, ecologically sound substitutes for fully petroleum-based plastics targeting primarily durable goods, packaging applications. The Company offers six commercial grades of Sustainable resins in this product line. Cereplast Hybrid Resins products replace up to 55% of the petroleum content in conventional plastics with bio-based materials, such as industrial starches sourced from plants. The Hybrid resins line is designed to offer similar properties to traditional polyolefins, such as impact strength and heat deflection temperature, and is compatible with existing converter processes and equipment. The first commercial product with Cereplast Algae Plastic resin is being produced and sold as part of the Company's Sustainables resin family.

The Co! mpany's Compostable resins are renewable substitutes for petroleum-based plastics targe ting primarily single-use disposables. The Company's Compost! able Resins have been used to produce foodservice ware, including the first line of fully biodegradable and compostable foodservice ware. Cereplast Hybrid Resins uses renewable materials such as starches from corn and tapioca.

Cereplast competes with BASF, Dow Chemical, Lyondell Basell, DuPont, SABIC, Novamont, NatureWorks and Telles.

Advisors' Opinion:

• [By Bryan Murphy]

  The whole thing may seem a little "out there" at first glance, but truth be told, what Metabolix, Inc. does isn't terribly unusual anymore. It's just a little less sexy than what traders and stock speculators usually want to see and hear with their picks. Kraton Performance Polymers Inc. (NYSE:KRA) and the now-bankrupt Cereplast Inc. (OTCMKTS:CERPQ) are/were in the same business, along with several others. [Don't let the Cereplast bankruptcy filing deter you - it wasn't a lack of opportunity that up-ended CERP.]

source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-chemical-stocks-for-2016-2.html

5 Best Asian Stocks To Watch Right Now

5 Best Asian Stocks To Watch Right Now: Cott Corp (COT)< /h3>

Cott Corporation (Cott), incorporated on December 31, 2006, is a producers of beverages on behalf of retailers, brand owners and distributors. The Company's product lines include carbonated soft drinks (CSDs), 100% shelf stable juice and juice-based products, clear, still and sparkling flavored waters, energy products, sports products, new age beverages, and ready-to-drink teas, as well as alcoholic beverages for brand owners. The Company operates in five segments: North America (which includes the United States operating segment and Canada operating segment), the United Kingdom (which includes its United Kingdom reporting unit and its Continental European reporting unit), Mexico, Royal Crown International (RCI) and All Other. The Company markets or supplies over 500 retailer, licensed and Company-owned brands in its four core geographic segments. In March of 2012, its U.K. reporting segment acquired a beverage and wholesale business based in Scotland.

Advisors' Opinion:

• [By kcpl]

  It wasn't a good quarter for Cott Corporation (COT) as the company had trouble with its volumes. Cott Corporation engages in the production and distribution of retailer brand beverages in North America and globally. It offers carbonated soft drinks, flavored waters, energy-related drinks, juice, juice-based products, bottled water and ready-to-drink teas. It primarily serves grocery, mass-merchandise, drugstore, wholesale and convenience store chains.

• [By Rick Munarriz]

  It's been a year of brand-widening initiatives for SodaStream, and not just because it cranked out its first Super Bowl ad back in February.

  In February it teamed up with Ocean Spray to co-develop cranberry juice blends exclusively for the SodaStream system. This follows deals last year with Crystal Light, Kool-Aid, and V8 for non-conventiona! l carbonated beverages. My 2012 wish for SodaStream to strike a deal with Monster Beverage (NASDAQ: MNST  ) to make a bigger splash in the energy-drinks market hasn't materialized, but a deal with EBOOST did happen earlier this year. The initial natural energy drink flavors of orange and acai pomegranate will hit the market as SodaStream syrups during the latter half of this year, packing an all-natural energy boost and vitamins in every serving. EBOOST doesn't have the same allure as Monster or Red Bull, but the move was still a strong one since there's a real value proposition for home-crafted energy drinks. If SodaStream is successful, the big boys will be on notice. In March, SodaStream, which is based in Israel, teamed up with private-label bottler Cott (NYSE: COT  ) to produce SodaStream's existing flavors at its facility in Georgia, making it easier to get SodaStream products into the country with the world's largest soda consumption per capita.

  The next chapter in what has been a successful year will naturally write itself on Wednesday. There is plenty to prove, even after SodaStream proves quarter after quarter that it's not just a company behind a faddish novelty.

• [By Dan Caplinger]

  But SodaStream is continuing to pull out all stops in order to improve its results. SodaStream's recent partnership with Samsung to incorporate carbonation technology into high-end refrigerators could help drive growth for consumers who don't want to deal with a separate appliance in their kitchens. Moreover, SodaStream's deal in March with bottler Cott (NYSE: COT  ) to produce soda syrup within the U.S. should help it boost its efficiency in getting flavors to domestic customers.

source from Top Stocks For 2015:http://www.topstocksblog.com/5-best-asian-stocks-to-watch-right-now-4.html

Top 10 Building Product Companies To Buy Right Now

LONDON -- After a busy month or so for company reports, we're heading into a quiet patch over the next few weeks as the end-of-March reporting season draws to a close. There won't be a lot to keep us alert next week, but we will have a small handful of important updates.

Here we take a quick look at two FTSE 100 companies and one from the FTSE 250 that are bringing us news in the coming week.

Wolseley (LSE: WOS  )
We're expecting a third-quarter update from Wolseley on Tuesday, and if things are still going as they were at the halfway stage, announced in March, investors will probably be pleased -- though with the share price up nearly 50% over the past 12 months to 3,353 pence, they're probably already quite happy.

Like-for-like revenue at the plumbing, heating, and building products supplier was up 2.2% for the six months to Jan. 31, and with margins improving, the firm managed to convert that to a 7.6% rise in trading profit and a 3.9% rise in headline earnings per share. The interim dividend was lifted by 10% to 22 pence per share. Net debt was up to 拢871 million from 拢470 million at the same stage the previous year, but against revenue of 拢6.3 billion, that's not a massive sum.

5 Best Building Product Stocks For 2016: Drew Industries Inc (DW)

Drew Industries Incorporated, incorporated on March 20, 1984, is a supplier of components for recreational vehicle (RVs) and manufactured housing. The Company operates in two segments: the RV products segment (RV Segment), and the manufactured housing products segment (MH Segment). The Company��s operations are conducted through its wholly owned subsidiaries, Lippert Components, Inc. and its subsidiaries (Lippert) and Kinro, Inc. and its subsidiaries (Kinro), each of which has operations in both the RV Segment and the MH Segment. During the year ended December 31, 2012, the RV Segment accounted for 87% of net sales and the MH segment accounted for 13% of net sales. On February 21, 2012, the Company acquired the business and certain assets of the United States RV entry door operation of Euramax International, Inc. In February 2014, the Company's wholly-owned subsidiary, Lippert Components, Inc has acquired Innovative Design Solutions, Inc. (IDS).

RV Segment

The Company through its wholly owned subsidiaries manufactures and markets a variety of products used in the production of RVs, including steel chassis for towable RVs, axles and suspension solutions for towable RVs, slide-out mechanisms and solutions, thermoformed bath, kitchen and other products, manual, electric and hydraulic stabilizer and lifting systems, aluminum windows and screens, chassis components, furniture and mattresses, entry, baggage, patio and ramp doors, entry steps, awnings, and other accessories. The Company also supplies certain of these products to the RV aftermarket, and to adjacent industries, including manufacturers of truck caps, buses and trailers used to haul boats, livestock, equipment and other cargo. Operations of the Company's RV Segment consist primarily of fabricating, welding, painting and assembling components into finished products. The Company's RV Segment operations are conducted at 23 manufacturing and warehouse facilities throughout the United States, located in proximity to the cus! tomers they serve. Of these facilities, six also conduct operations in the Company's MH Segment. It markets extruded aluminum parts to manufacturers in other industries. The Company's RV Segment products are sold primarily to manufacturers of RVs such as Thor Industries Forest River (a subsidiary of Berkshire Hathaway, and other original equipment manufacturers (OEMs), and to distributors of aftermarket products.

MH Segment

The Company through its wholly owned subsidiaries manufactures and markets a variety of products used in the production of manufactured homes and to modular housing and mobile office units, including vinyl and aluminum windows and screens, steel chassis, steel chassis parts, axles, thermoformed bath and kitchen products, steel and fiberglass entry doors, and aluminum and vinyl patio doors. The Company also supplies windows, doors, and thermoformed bath products as replacement parts to the manufactured housing aftermarket, and to adjacent industries. MH Segment customers manufacture both manufactured homes and modular homes, and certain of the products manufactured by the Company are suitable for both types of homes. Operations of the Company's MH Segment consist primarily of fabricating, welding, thermoforming, painting and assembling components into finished products. The Company's MH Segment operations are conducted at 13 manufacturing and warehouse facilities throughout the United States, located in proximity to the customers they serve. Of these facilities, six also conduct operations in the Company's RV Segment. The Company's manufactured housing products are sold primarily to producers of manufactured homes such as Clayton Homes, Cavco Industries, Inc., Champion Home Builders, Inc., Skyline Corporation, and other OEMs, and to distributors of aftermarket products.

The Company competes with Kober Corporation and Dexter Axle Company.

Advisors' Opinion:

• [By John Udovich]

  The CEO of recreation vehicle (RV) stock Winnebago Industries, Inc (NYSE: WGO) recently appeared on CNBC to say that the economy is improving for RV makers, meaning its time to take a closer look at the stock plus take a look at the performance of other small cap RV stocks like Drew Industries, Inc (NYSE: DW), Skyline Corporation (NYSEMKT: SKY) and Thor Industries, Inc (NYSE: THO).

Top 10 Building Product Companies To Buy Right Now: Renaissance Oil Corp (ROE)

Renaissance Oil Corp, formerly San Antonio Ventures Inc., is developing a diversified shale and mature fields portfolio for development in Mexico and Spain. The Company is partnered with Grupo SAMCA, a diverse industrial with operations in energy, mining, industrial minerals, agriculture, environmental and various other business lines in Spain. Advisors' Opinion:

• [By Canadian Value]

  In our opinion, the biggest drawback to using multiples is that this method does not explicitly consider whether the fundamental drivers of business value embedded in the multiple are reasonable. For example, the formula below tells us that a company��s forward P/E ratio is a function of its cost of equity, return on equity (ROE), reinvestment ratio and payout ratio:

• [By Damian Illia]

  Regarding profitability measures, return on equity (ROE) and return on assets (ROA) are at negative levels. We have seen the evolution for the prior ten years of ROE in a previous article.

• [By Holly LaFon]

  Question: What is your view on Travelers (TRV)��s competitive advantage? How troubling is the huge fixed-income portion of their investment portfolio (in relation to future inflation)? How much do you like Jay Fishman? I really like the fact they are aggressively repurchasing shares and the fact that it is trading at book value, which I estimate to earn around 13% (ROE).

Top 10 Building Product Companies To Buy Right Now: Fomento Economico Mexicano SAB de CV (FOMC)

Fomento Economico Mexicano SAB de CV (FEMSA) is a Mexico-based holding company engaged in the beverages industry. Through its subsidiary Coca-Cola FEMSA SAB de CV, the Company is active in the production and distribution of a variety of non-alcoholic beverages, bottled water and still beverages such brands as Coca-Cola, Fanta, Sprite, Powerade, Delaware Punch and other trademark beverages of The Coca-Cola Company in Mexico. Through FEMSA Comercio SA de CV, it operates the OXXO convenience-store chain in Latin America. The Company operates in a number of Latinamerican countries and in Philippines. Advisors' Opinion:

• [By CanadianValue]

  Former Philadelphia Fed President Edward Boehne elegantly described the approach at a Federal Open Market Committee (FOMC) meeting in late 1989:

  ��Now, sooner or later, we will have a recession. I don��t think anybody around the table wants a recession or is seeking one, but sooner or later we will have one. If in that recession we took advantage of the anti-inflation (impetus) and we got inflation down from 4 1/2 percent to 3 percent, and then in the next expansion we were able to keep inflation from accelerating, sooner or later there will be another recession out there. And so, if we could bring inflation down from cycle to cycle just as we let it build up from cycle to cycle, that would be considerable progress over what we��ve done in other periods in history.��

• [By Canadian Value]

  Also interesting is that the duration of rising rate environments is distinctly shorter after 1982. The average duration declines to 14 months from 40 months prior to 1982. A possible explanation could be changes in the monetary mechanism influencing interest rates. In 1982, the Federal Open Market Committee (FOMC) first referenced a targeted federal funds rate.7

Top 10 Building Product Companies To Buy Right Now: Genomma Lab Internacional SAB de CV (LABB.MX)

Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company��s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. Advisors' Opinion:

• [By Ben Levisohn]

  He then took a deep dive into Genomma Lab�(LABB.MX), a Mexican producer of over-the counter pharmaceuticals, generic drugs, and personal care products. Now, I’m sitting with a Chromebook in a large auditorium, so I hope I’ve captured the essence of his argument.

Top 10 Building Product Companies To Buy Right Now: Telecom Italia S.P.A.(TI)

Telecom Italia S.p.A., together with its subsidiaries, provides fixed-line and mobile telecommunications, Internet, and media services. The company also operates in office and system solutions. Its portfolio ranges from consumer-focused convergent communications services to business-oriented advanced ICT solutions. The company?s integrated range of offerings, proprietary platforms, and network architecture leverage the potential of fixed-line and mobile broadband to offer convergent solutions for communication, Web surfing, always-in-touch services, and serve as a gateway to the digital world from the home, the office, and on the move, from fixed-line telephone, cell phone, PC, or TV. Its business portfolio covers various categories of business needs, from freelance professionals to SMEs, corporations, institutions, and public government bodies. The company?s Web offerings combine Italy?s Virgilio portal with Web 2.0 ventures, such as Yalp!, a TV community where users p ublish their own content and create their own TV channels. Its media operations span traditional broadcasting over analogue and digital networks, and mobile broadcasting through TIM/MTV partnership vehicle, MTV Mobile. The company has operations in Italy, Latin America, Germany, Holland, and the Mediterranean basin. As of December 31, 2009, it provided fixed telecommunications services with approximately 16.1 million physical accesses in Italy. The company?s wholesale customer portfolio consisted of approximately 6.2 million accesses for telephone services; and broadband portfolio had approximately 8.7 million accesses in Italy, as well as 30.8 million mobile telephone lines. Telecom Italia was founded in 1908 and is headquartered in Milan, Italy.

Advisors' Opinion:

• [By Sean Williams]

  Don't forget the cash flow
  With austerity measures hitting home in Europe, it's fairly easy to understand why Telecom Italia (NYSE: TI  ) (NYSE: TI-A  ) , Italy's largest telephone service provider, has struggled mightily. Unlike in the U.S., where a landline or cell phone are viewed as practical necessities, consumers in Italy have had no problem giving up their landlines, or businesses postponing their network expansion, until Italy's economy improves. In fact, in Telecom Italia's first-quarter report, we saw EBITDA decline 10%, to $3.5 billion, and overall sales dip 8%.

• [By Jon C. Ogg]

  Telecom Italia (NYSE: TI) was started as Buy at Goldman Sachs, just a day after J.P. Morgan raised it to Neutral from Underperform.

  Under Armour Inc. (NYSE: UA) was raised to Neutral from Underweight at J.P. Morgan.

• [By DAILYFINANCE]

  Steven Senne/AP NEW YORK -- Target (TGT) massive data breach over the holidays helped push its fourth-quarter profit down 46 percent. The discount retailer also said Wednesday that sales fell 5.3 percent as the breach scared off customers. The nation's second-largest discounter also offered a profit outlook below Wall Street expectations as the costs of the breach that affected millions of credit and debit card customers linger. The discounter, based in Minneapolis, said it earned $520 million, or 81 cents a share, for the three months that ended Feb. 1. That compares with a profit of $961 million, or $1.47 a share a year earlier. Revenue fell to $21.5 billion from $22.7 billion. Revenue at stores open at least a year, an important retail measurement, fell 2.5 percent. Analysts had expected a profit of 80 cents on revenue of 21.5 billion, according to FactSet estimates. The breach resulted in $17 million of net expenses in the fourth quarter, Target said, with $61 million of total expenses partially offset by the recognition of a $44 million insurance receivable. Shares of Target rose 99 cents to $57.50 in premarket trading Wednesday as earnings results beat Wall Street estimates by a penny. The stock has fallen about 10 percent since the company disclosed the breach in mid-December. "As we plan for the new fiscal year, we will continue to work tirelessly to win back the confidence of our guests. We are encouraged that sales trends have improved in recent weeks," Gregg Steinhafel, chairman, president and CEO of Target, said in a statement. The results underscore the big challenges that Steinhafel faces. Even before the breach, Target has struggled with uneven sales since the recession as its middle-income shoppers are still not comfortable in spending. And the company has also grappled with the perception that its prices are too high. Critics also say that the discounter, known for its exclusive limited partnerships with designers, has lost its

• [By DAILYFINANCE]

  Brent Lewin/Bloomberg via Getty Images NEW YORK -- Facebook (FB) is placing a $19 billion bet on reaching its next billion mobile users with the acquisition of WhatsApp, a popular messaging service that lets people send texts, photos and videos on their smartphones. The $19 billion deal is by far Facebook's largest and bigger than any that Google (GOOG), Microsoft (MSFT) or Apple (AAPL) have ever done. But it is likely to raise worries that Facebook and other technology companies are starting to become overzealous in their pursuit of promising new products and services, said Anthony Michael Sabino, a St. John's University business professor. "This could be seen as a microcosm of a bubble," Sabino said. "I expect there to be a lot of skepticism about this deal. People are going to look at this and say, 'Uh-oh, did they pay way too much for this?" Facebook, for its part, is taking the long view. WhatsApp has 450 million monthly users, 70 percent of whom use it every day. The service is adding a million new users a day. There are 19 billion messages sent and 34 billion received via WhatsApp each day, in addition to 600 million photos and 100 million video messages. At this rate, Facebook CEO Mark Zuckerberg is confident the app will reach a billion users. Services that reach that milestone, Zuckerberg said in a statement, "are all incredibly valuable." It's an elite group to be sure -- one that includes Google (which owns YouTube), Facebook itself and little else. Facebook said Wednesday that it's paying $12 billion in stock and $4 billion in cash for WhatsApp. In addition, the app's founders and employees -- 55 in all -- will be granted restricted stock worth $3 billion that will vest over four years after the deal closes. The transaction translates to roughly 11 percent of Facebook's market value. In comparison, Google's biggest deal was its $12.5 billion purchase of Motorola Mobility, while Microsoft's largest was Skype at $8.5 billion. Apple, meanwhil

Top 10 Building Product Companies To Buy Right Now: CapitalSource Inc (CSE)

CapitalSource Inc., through its subsidiaries, provides financial products to small and middle market businesses in the United States. It offers depository products and services, such as savings and money market accounts, individual retirement account products, and certificates of deposit. The company also provides senior secured real estate and asset-based loans, and cash flow loans, which have a first priority lien in the collateral securing the loan. Its asset-based loans are collateralized by specified assets of the client, primarily the client�s accounts/notes receivable, inventory, and machinery; and real estate loans are secured by senior mortgages on real property. The company focuses on providing equipment loans and leases; loans to healthcare providers; commercial real estate and multifamily real estate loans; loans secured by timeshare, auto, and other consumer receivables; student loans; traditional life insurance premium finance loans; and loans to technology companies, small businesses, dentists, physicians, pharmacists, and optometrists, as well as to companies in the physical security, government security, and public safety sectors. It operates through 21 retail bank branches in southern and central California, as well as lending offices in the United States. The company was founded in 2000 and is headquartered in Los Angeles, California.

Advisors' Opinion:

• [By Nicole Seghetti]

  Let's take a closer look at three stocks Fisher recently bought, including drugmaker Gilead Sciences (NASDAQ: GILD  ) , materials manufacturer Owens Corning (NYSE: OC  ) , and financial services provider CapitalSource (NYSE: CSE  ) .

Top 10 Building Product Companies To Buy Right Now: United Technologies Corporation(UTX)

United Technologies Corporation provides technology products and services to the building systems and aerospace industries worldwide. The company?s Otis segment designs, manufactures, sells, and installs passenger and freight elevators, escalators, and moving walkways, as well as provides maintenance and repair services. Its Carrier segment offers heating, ventilating, air conditioning, and refrigeration systems, controls, services, and energy-efficient products for residential, commercial, industrial, and transportation applications. The company?s UTC Fire and Security segment provides electronic security products comprising intruder alarms, and access control and video surveillance systems; fire safety products, such as specialty hazard detection and fixed suppression products, fire extinguishers, fire detection and life safety systems, and other firefighting equipment; systems integration, video surveillance, installation, maintenance, and inspection services; and mon itoring, response, and security personnel services. Its Pratt and Whitney segment supplies aircraft engines for the commercial, military, business jet, and general aviation markets; industrial gas turbines; geo thermal power systems; and space propulsion systems, as well as provides fleet management, maintenance, repair, and overhaul services. The company?s Hamilton Sundstrand segment supplies aerospace products, such as power generation, management and distribution, flight control, engine control, environmental control, auxiliary power units, and propeller systems; and industrial products, including air compressors, metering pumps, and fluid handling equipment under the Sullair, Sundyne, and Milton Roy names. Its Sikorsky segment manufactures military and commercial helicopters, as well as offers aftermarket helicopter and aircraft parts and services. United Technologies Corporation was founded in 1934 and is based in Hartford, Connecticut.

Advisors' Opinion:

• [By Travis Hoium]

  United Technologies (NYSE: UTX  ) rose 3.9% to lead the Dow, mostly on positive economic news. A diversified company like United Technologies will benefit from stronger economic activity indicated by the jobs report. Subsidiary UTC Aerospace also announced a deal with ST Aerospace to provide maintenance, repair, and overhaul for Boeing 787 Dreamliner engines worldwide. �

• [By Dan Carroll]

  United Technologies' (NYSE: UTX  ) shares are up 1.3%, and this company is also hoping to strike it rich in Paris. UTC subsidiary Pratt & Whitney believes it will strike a new deal with the Pentagon to supply engines for the Department of Defense's new F-35 fighter in the next 30 days. Military jet-engine sales provide billions of dollars of revenue for Pratt & Whitney each year, and sales of F-35 engines alone could reach $2 billion annually in the coming years.

Hot International Stocks To Invest In 2016

Hot International Stocks To Invest In 2016: Prudential Public Limited Company(PUK)

Prudential plc provides retail financial products and services, and asset management services to individuals and businesses in Asia, the United States, and the United Kingdom. It offers savings, protection, investment, and unit-linked products; manages investments across a range of asset classes for internal, retail, and institutional clients; manages onshore mutual funds; and provides retirement planning, consumer and Islamic finance, and health solutions. The company also provides retirement savings and income solutions; variable annuities; fixed and fixed index annuities; term life, universal life, and variable universal life insurance; permanent individual life insurance; and institutional products, such as guaranteed investment contracts, funding agreements, and medium term note funding agreements. In addition, it offers pensions and annuities; investment plans; and car, health, home, travel, and protection insurance policies. Further, Prudential plc provides fund man agement services for individual and institutional clients. The company was founded in 1848 and is based in London, the United Kingdom.

Advisors' Opinion:

• [By Patricio Kehoe]

  In fact, today the company announced that it will be launching a new universal life product for the Canadian market called Manulife UL by May 26 of this year. The new product will offer cost-effective insurance protection, as well as the opportunity for tax-advantaged investing, catering to customer's demands for a more simplified insurance solution, which should help boost sales to some extent. Although the firm's balance sheet is highly leveraged, exposing it to possible damages in the case of higher-than-expected policy liabilities, Manulife's capital position has improved substantially over the past year. With a ratio of regulatory cap! ital to capital required at 248%, the firm possesses excessive capital levels, well above competitors like Prudential Public Limited Company (ADR) (PUK), China Life Insurance Company Ltd. (ADR) (LFC), and Sun Life Financial Inc. (USA) (SLF), which all sport a 200% ratio. Moreover, the company's excessive capital should allow it to maintain the above average dividend yield of 2.66% offered to shareholders.

• [By Rupert Hargreaves]

  Today, I am looking at Prudential  (LSE: PRU  ) (NYSE: PUK  ) to determine whether you should consider buying the shares at 1,097p.

source from Top Stocks For 2015:http://www.topstocksblog.com/hot-international-stocks-to-invest-in-2016-2.html

Top 5 Services Stocks To Invest In 2016

Top 5 Services Stocks To Invest In 2016: Fleetmatics Group PLC (FLTX)

Fleetmatics Group PLC (FleetMatics), incorporated on October 28, 2004, is a provider of fleet management solutions delivered as software-as-a-service (SaaS). The Company offers Web-based and mobile application solutions, which provide fleet operators with visibility into vehicle location, fuel usage, speed and mileage and other insights into their mobile workforce. The Company offers fleet management software solutions. The Company's FleetMatics-branded solutions sold under the FleetMatics or SageQuest names. Its solutions are accessed through a Web browser or mobile application and provide its customers with actionable business intelligence. Its SaaS offering consists of the easy-to-use components: Tracking Alerts, Route Replay, Geofencing and Landmarks, FleetTracking Dashboard, Fleet Reports, Mobile App, Speed Limits, Panoramic Reporting and Benchmarking. In addition to this core SaaS offering, it also offers the additional features to its customers: Fuel Card Reportin g Integration, FleetMatics Fuel Card and Navigation Unit Integration. Effective August 8, 2013, Fleetmatics Group PLC a unit of Fleetmatics Investor Holdings LP, acquired Connect2Field Holdings Pty Ltd.

The Company's Fleet Tracking Alerts allow fleet operators to set driver performance thresholds and receive e-mail notifications when unwanted driving behavior occurs. Notifications are sent when a vehicle enters or exits specified areas, moves during specified times, or when a vehicle's speed or idle time exceeds specified thresholds. Its Route Replay feature allows customers to play back each journey taken by their vehicles, from start up to shut down and provides customers with minute-by-minute location and speed details. Fleet operators can start, stop, pause, and change the speed of the journey replay using intuitive playback controls to monitor a! nd analyze driver behavior. Integration with Google Maps enables customers to pinpoint vehicle location with s atellite, street views and zooming capabilities.

The Company's Geofencing and Landmarks feature allows customers to designate areas on the map, in which vehicles are allowed or not allowed to travel. Fleet operators receive notifications when a vehicle enters or exits an unauthorized location and reports are generated detailing time spent in unauthorized areas. Its FleetTracking Dashboard provides fleet operators with a way to monitor overall fleet performance through a graphical summary. This interface allows fleet operators to evaluate performance categories across their fleet, including speed, engine on-time, vehicle idling, vehicle mileage and number of stops. Fleet operators can also view individual vehicle performance.

The Company provides its customers with over 40 pre-built on-demand reports, which they can access to analyze fleet data. Its reports contain information about vehicle movement and use, including vehicle location, ignition on and off time, engine idle time, arrival and departure times, distance traveled, hours worked, and vehicle speed. Its Mobile App is a portable software application, which fleet operators can use to access actionable business intelligence and insights over mobile devices. It includes the FleetTracking Dashboard, Reports, Tracking Alerts, Route Replay, and Geofencing and Landmarks.

With the Company's Speed Limits feature, the Company provides a range of speed limit information across all types of roads and geographies, including local and residential roads. Speed limit is powered by FleetMatics RoadSpeed, a specialized database of average speed values derived from billions of points of vehicle movement. Its panoramic reporting engine features in-depth historical trending analyses and strategic comparative information from the customers, such as driver and organizational performance benchmarking. Its Fuel Ca! rd Report! ing Integration feature integrates customers' fuel card usage information into its fleet management softwa re platform. It provides its customers with an on-demand fue! l usage s! ummary for an entire fleet, as well as detailed information on individual vehicles. Reports are generated, which compare fuel purchases with vehicle location data.

The Company has partnered with an independent global fleet card provider to deliver a Universal Platinum MasterCard. Its Navigation Unit Integration features with Garmin global positioning system (GPS) navigation devices, streamlines dispatching and communication by integrating its fleet management software with its customers' GPS navigation devices. It provides customers with turn-by-turn directions, notification of job status, estimated time of arrival to the next job site, and easy-to-use messaging capabilities. Drivers receive automatic job updates, eliminating the need to manually enter addresses while driving. It offers customers the choice of two fleet management branded solutions, FleetMatics and SageQuest.

Advisors' Opinion:

• [By Tom Taulli]

  CSOD stock is currently trading at a fair valuation for cloud companies, with a price-to-sales ratio of 9.

  Cloud Companies to Buy: Fleetmatics (FLTX)

  When it comes to cloud companies, Fleetmatics (FLTX) stock is downright cheap. The stock trades at only five times sales, and the forward price-to-earnings ratio is 24.

• [By John Kell]

  FleetMatics Group Ltd.'s(FLTX) fourth-quarter earnings more than tripled as a tax benefit helped boost the bottom line, along with a jump in revenue. However, shares slumped 18% to $32.60 premarket as the company’s earnings outlook fell markedly short of Wall Street’s expectations.

• [By Louis Navellier]

  Fleetmatics Group (FLTX) is another Europe stock with the characteristics needed to be a leader in the European markets this year. The company makes software that allows operat! ors of co! mmercial vehicle fleets to track vehicles and learn about vehicle location, fuel usage, speed and mileage. The Irish company has seen earnings explode this year with growth of more than 700% in bottom-line profit increases.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-5-services-stocks-to-invest-in-2016.html

Best Warren Buffett Companies To Own In Right Now

Best Warren Buffett Companies To Own In Right Now: BP p.l.c.(BP)

BP p.l.c. provides fuel for transportation, energy for heat and light, retail services, and petrochemicals products. Its Exploration and Production segment engages in the oil and natural gas exploration, field development, and production; midstream transportation, and storage and processing; and marketing and trading of natural gas, including liquefied natural gas (LNG), and power and natural gas liquids (NGL). This segment has exploration and production activities in Angola, Azerbaijan, Canada, Egypt, Norway, Russia, Trinidad and Tobago, the United Kingdom, and the United States, as well as in Asia, Australasia, South America, North Africa, and the Middle East. This segment also owns and manages crude oil and natural gas pipelines; processing facilities and export terminals; and LNG processing and transportation, as well as NGL extraction facilities. BP p.l.c. has interests in the Trans-Alaska pipeline system, the Forties pipeline system, the Central Area transmission sys tem pipeline, the South Caucasus Pipeline, and Baku-Tbilisi-Ceyhan pipeline, as well as in LNG plants located in Trinidad, Indonesia, and Australia. The company?s Refining and Marketing segment involves in the supply and trading, refining, manufacturing, marketing, and transportation of crude oil, petroleum, and petrochemicals products and related services to wholesale and retail customers primarily under the BP, Castrol, ARCO, and Aral brands. Its Other Businesses and Corporate segment produces and markets rolled aluminum products, as well as generates energy through wind, solar, biofuels, hydrogen, and carbon capture and storage sources; and engages in shipping activities. The company was founded in 1889 and is headquartered in London, the United Kingdom.

Advisors' Opinion:

• [By Aaron Levitt]

  Were in the thick of earnings season for the energy sector and BP (BP) and Occidental Petroleum (OXY) were the latest oil stocks to! report earnings.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/best-warren-buffett-companies-to-own-in-right-now-3.html

Top 10 Building Product Stocks For 2016

Top 10 Building Product Stocks For 2016: Lloyds Banking Group PLC (LYG)

Lloyds Banking Group plc, incorporated on October 21, 1985, is a holding company. The Company is a financial services group providing a range of banking and financial services, primarily in the United Kingdom, to personal and corporate customers. The Company operates in four segments: Retail, Commercial Banking, Wealth, Asset Finance and International and Insurance. Retail provides banking, mortgages and other financial services to personal customers in the United Kingdom. Commercial Banking provides banking and related services to business clients, from small businesses to large corporate. Wealth, Asset Finance and International provides private banking and asset management and asset finance in the United Kingdom and overseas and operates the Companys international retail businesses. Insurance provides long term savings, protection and investment products in the United Kingdom and Europe and provides general insurance to personal customers in the United Kingdom.

Retail

The Retail division operates the retail bank in the United Kingdom and is a provider of current accounts, savings, personal loans, credit cards and mortgages. This includes a range of current accounts including packaged accounts and basic banking accounts. It is also the provider of personal loans in the United Kingdom, as well as being the United Kingdoms credit card issuer. Retail is the private sector savings provider in the United Kingdom. It is also a general insurance and bancassurance distributor, offering a range of long-term savings, investment and general insurance products.

Commercial Banking

The Commercial Banking division supports the Companys business clients from small businesses to corporate. Commercial Banking provides support to corporate clients through the provision of core banking products, such as lending, deposits and transaction banking services whilst also offering clients expe! rtise in capita l markets (private placements, bonds and syndicated loans), ! financial markets (foreign exchange, interest rate management, money market and credit) and private equity.

Wealth, Asset Finance and International

Wealth, Asset Finance and International consists of the Companys the United Kingdom and international wealth businesses, the Companys the United Kingdom and international asset finance and online deposit businesses along with its international retail businesses. The Wealth business consists of private banking and asset management. Wealths private banking operations cater to the range of wealth clients from affluent to Ultra High Net Worth within the United Kingdom, Channel Islands and Isle of Man, and internationally. Asset Finance consists of a number of leasing and speciality lending businesses in the United Kingdom, including Lex Autolease and Black Horse Motor and Personal Finance along with its leasing and specialty lending businesses in Australia and its European online deposit business. T he international business comprises its non-core banking business outside the United Kingdom, with the exception of corporate business written through the Commercial Banking division. This primarily consists of Ireland, Retail Europe and Asia.

Insurance

The Insurance division provides long-term savings, protection and investment products and general insurance products to customers in the United Kingdom and Europe. The United Kingdom Life, Pensions and Investments business provides long-term savings, protection and investment products distributed through the bancassurance, intermediary and direct channels of the Lloyds TSB, Halifax, Bank of Scotland and Scottish Widows brands. The European Life, Pensions and Investments business distributes products primarily in the German market under the Heidelberger Leben and Clerical Medical brands. The General Insurance business is a distributor of home insurance in the United Kingdom, with products! sold thr! ough the branch network, direct channels and strategic corporate! partners! . It operates primarily under the Lloyds TSB, Halifax and Bank of Scotland brands.

Advisors' Opinion:

• [By Stuart Watson]

  LONDON --A short statement fromLloyds Banking Group (LSE: LLOY  ) (NYSE: LYG  ) about its capital position helped its shares to rise on Wednesday morning, taking its one-month gain to nearly 35%.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-10-building-product-stocks-for-2016-2.html

Mid-Cap Stocks Win Favor at ABN on Outlook for Growth

ABN Amro Private Banking is betting that smaller companies will benefit the most as corporations boost spending in 2014 amid the fastest global economic growth in four years.

Smaller firms will rally the most among equities worldwide as they provide the tools and goods needed for larger companies to grow, according to ABN Amro's wealth-management unit. Improving economic indicators mean the biggest companies will be more willing to increase expenditure and may look to acquire smaller competitors to support expansion, said Didier Duret, chief investment officer for the private bank.

"These companies are at the crossroads of innovation and new demand, and tend to benefit in the middle of an economic recovery," Amsterdam-based Duret, who helps oversee 164.5 billion euros ($220 billion), said in a phone interview yesterday. "Increased confidence and domestic drivers are why we've selected small- and medium-cap stocks in what is now a more mature market. The last time we did that was in 2005."

Earnings at companies in the MSCI World Mid-Cap Index will surge 93 percent in the three years through 2015, while profit for the benchmark MSCI World Index will advance 47 percent, according to analysts' estimates compiled by Bloomberg. The measure of mid-size stocks has rallied 19 percent this year through yesterday, while the gauge of the largest developed-market shares rose 16 percent.

In the U.S., the Standard & Poor's Mid-Cap 400 Index has climbed 21 percent in 2013, while the S&P 500 gauge of the largest companies has gained 19 percent.

Expedia, Arcadis

Companies like Expedia Inc. (EXPE), which provides online travel booking services, and Arcadis NV (ARCAD), a Dutch designer of bridges and dikes, are likely to increase profit at a faster pace than larger firms during an improving economy, Duret said. Smaller companies are also less leveraged, with U.S. mid-caps holding 46 percent less debt per share than firms listed on the S&P 500, data compiled by Bloomberg show.

Duret increased his equity allocation to 44 percent of assets in September from 40 percent in June. ABN Amro predicts the global economy will expand 3.8 percent in 2014. That would be the fastest pace since 2010 and more than the 2.9 percent growth projected by economists in a Bloomberg survey. The bank cut its cash holdings to 9 percent from 13 percent, according to a report published today.

ABN Amro's wealth-management unit maintained its overweight position in stocks for a fifth consecutive quarter, meaning it holds more of the assets than represented in benchmark portfolios.

"It looks like we are getting out of the woods, and it's widely spread and evenly distributed across the developed regions," said Duret. "There's a constructive scenario ahead of us where many forecasters may be surprised by the cumulative effect within the economy. It has been the longest recession I've seen in my career, and it's due time we got out it."

Best Transportation Companies For 2016

Best Transportation Companies For 2016: Western Refining Logistics LP (WNRL)

Western Refining Logistics, LP, incorporated on July 17, 2013, owns, operates, develops, and acquires terminals, storage tanks, pipelines, and other logistics assets. As of December 31, 2012, the Companys assets includes pipeline and gathering assets and terminalling, transportation, and storage assets in the Southwestern portion of the United States, which included approximately 300 miles of pipelines and approximately 7.9 million barrels of active storage capacity, as well as other assets. The Company's assets are integral to the operations of Westerns refineries located in El Paso, Texas, and near Gallup, New Mexico.

As of December 31, 2012, the Company owns and operates two refineries, in El Paso, Texas and Gallup, New Mexico, with a total crude oil throughput capacity of 153,000 barrels per day (bpd). The Company does not take ownership of the hydrocarbons or products (other than certain additives) that it handles or engages in the trading of any co mmodities.

Advisors' Opinion:

• [By Robert Rapier]

  Western Refining Logistics (NYSE: WNRL) debuted on Oct. 10. The partnership was formed by Western Refining (NYSE: WNR) to own, operate, develop and acquire terminals, storage tanks, pipelines, and other logistics assets. WNRL’s assets include 300 miles of crude oil pipelines, gathering systems, and 566,000 barrels of crude oil storage located primarily in the Permian Basin. Most of its revenue is expected to be derived from two 10-year, fee-based agreements with Western Refining.

• [By Aimee Duffy]

  It;s been a very robust year for master limited partnership IPOs to say the least. On Thursday, Western Refining (NYSE: WNR  ) successfully spun off its midstream logistics MLP, Western Refining Logistics (NYSE: WNRL  ) . The partnership became the 14th MLP to make its debut this year.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/best-transportation-companies-for-2016-2.html

Top 10 Insurance Stocks To Own Right Now

Top 10 Insurance Stocks To Own Right Now: Genworth Financial Inc (GNW)

Genworth Financial, Inc., a financial security company, provides insurance, wealth management, investment, and financial solutions in the United States and internationally. The company offers various insurance and fixed annuity products, including life and long-term care insurance products; payment protection insurance products for consumers primarily to meet specified payment obligations; and wealth management products, such as managed account programs with advisor support and financial planning services. It also provides mortgage insurance products and related services to insure prime-based, individually underwritten residential mortgage loans or flow mortgage insurance; and mortgage insurance on a structured or bulk basis, as well as offers services, analytical tools, and technology that enable lenders to operate and manage risk. In addition, the company provides institutional products consisting of funding agreements, funding agreements backing notes, and guaranteed in vestment contracts. Genworth Financial, Inc. distributes its products and services through financial intermediaries, advisors, independent distributors, affinity groups, and sales specialists. The company was founded in 2003 and is headquartered in Richmond, Virginia.

Advisors' Opinion:

• [By Garrett Cook]

  Shares of Genworth Financial (NYSE: GNW) were down 35.89 percent to $9.02 following Wednesday's earnings miss.

  Web.com Group (NASDAQ: WWWW) shares tumbled 21.63 percent to $15.87 after the company reported Q3 earnings of $0.63 per share on revenue of $143.80 million and announced a $100 million stock repurchase authorization. JP Morgan downgraded Web.com Group from Overweight to Neutral and lowered the price target from $35.00 to $20.00.

• [By Ben Levisohn]

  When a stock loses a third of its v! alue in one day, it’s fair to say that something has gone very wrong. In the case of Genworth Financial (GNW), you might want to add a few very’s.

• [By Ben Levisohn]

  Genworth Financial (GNW) has plunged 23% to $10.86 after the insurance company suffered a massive loss due to the rising costs of its long-term care insurance business.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-insurance-stocks-to-own-right-now-2.html

Top 5 Gas Utility Stocks To Watch Right Now

Top 5 Gas Utility Stocks To Watch Right Now: MedCAREERS Group Inc (MCGI)

MedCareers Group, Inc., incorporated on December 30, 2004, focus is to develop and build value through its wholly owned subsidiary Nurses Lounge (www.nurseslounge.com), an online professional network and communication source for nurses and organizations connected to the nursing community. On August 10, 2010, MedCareers acquired the workabroad.com Website from Steve Elisberg (Workabroad.com Website).

The Nurses Lounge is a professional network for nursing professionals providing relevant content and information and professional networking. Nurses can subscribe to Lounges created by nursing schools, nurse associations, employers, specialties and more to receive email updates of relevant news, events and other info. Professional networking is a place for nurses to connect with colleagues and network on a professional level.

Advisors' Opinion:

• [By Peter Graham]

  Last Friday, small cap stocks MedCAREERS Group Inc (OTCMKTS: MCGI), USmart Mobile Device Inc (OTCMKTS: UMDI) and Drinks Americas Holdings, Ltd (OTCMKTS: DKAM) were all over the place with the first two sinking 54% and 48.05%, respectively, while the last one rose 10.81%. It should be mentioned that all three small cap stocks have been the subject of paid promotions albeit none of these stocks have been over promoted. So where can investors and traders expect these stocks to head this week? Here is a quick look at what you might expect:

  MedCAREERS Group Inc (OTCMKTS: MCGI) Gets Additional Commitments to Join Its Subsidiary

  Small cap MedCAREERS Group aims to develop and build value through its wholly-owned subsidiary Nurses Lounge, Inc., an online professional network and communication source for nurses that offers a 21st century solution to recruitment and information that cannot be accomplished on a static nursing school or association website. On Friday, MedCAREERS Group sank 54% to $0.0575 for a ! market cap of $3.03 million plus MCGI is up 161.4% since the start of the year and down 93.9% over the past five years according to Google Finance.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-5-gas-utility-stocks-to-watch-right-now.html

Best Communications Equipment Stocks To Watch Right Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What:�Shares of Calix (NYSE: CALX  ) dropped more than 30% during intraday trading Wednesday after the communications equipment supplier reported mixed third-quarter results and weak forward guidance.

So what:�Quarterly revenue increased 27%, to a record $103.6 million, which translated to adjusted net income of $10.2 million, or $0.20 per share. Analysts, on average, were expecting lower adjusted earnings of $0.14 per share on higher sales of $104.35 million.

What's more, Calix stated that while spending from its tier 2 and tier 3 customers has been strong so far this year, those customers have indicated spending will slow down in the fourth quarter. As a result, management expects Q4 revenue to fall sequentially to a range of $97 million to $103 million, which will result in adjusted earnings per share in the range of $0.03 to $0.08.

10 Best Financial Stocks For 2016: Location Based Technologies Inc (LBAS)

Location Based Technologies, Inc. (LBT), incorporated on April 20, 2006, designs, develops, and sells personal, pet, and vehicle locator devices and services including PocketFinder People, PocketFinder Pets and PocketFinder Vehicles. The Company markets and sells consumer and commercial location devices and services. Its devices utilize Assisted Global Positioning System (A-GPS) and General Packet Radio Service (GPRS) technologies in conjunction with its technologies designed to enhance the families to interact and stay connected around the world. The Company is a developer of the PocketFinder family of products and the PocketFinder Network. The PocketFinder family of products includes the PocketFinder People, PocketFinder Vehicle, PocketFinder Pets, PocketFinder Luggage, PocketFinder Mobile and PocketFinder Fleet. The PocketFinder is a small location device that enables a user to locate a device, person, or pet, at anytime from almost anywhere. PocketFinder personal locator devices are wireless.

The Company generate revenue by selling its products and charging customers an ongoing service fee, for which it offers monthly and annual subscription plans. The Company�� product, PocketFinder, is a small, waterproof and wireless location device that enables users to locate anyone or anything they care about, from a computer or Web-enabled device. Its products deliver critical information to users, such as: device location, longitude, latitude, heading speed and 60 days of location history. This information can be viewed passively through a user�� account or can be sent to a user via email or push notification if the user sets an alert. The target markets for the PocketFinder include: young children, seniors, people with special needs and people who need to track valuable assets such as luggage or sporting equipment. In addition to the PocketFinder, it also sell the PocketFinder Pet and the PocketFinder Vehicle products. The PocketFinder Pet is designed for pets weighing 15 pounds or more,! and it markets the PocketFinder Vehicle to families with new drivers, car enthusiasts, motorcycle owners, watercraft owners and business fleets. The PocketFinder Vehicle attaches directly to a battery or fuse box, so it has a constant supply of power. All PocketFinder products operate on the same user interface, which enables its customers receive the same features, functionality and user-experience, regardless of which product they own. To access their account or locate their devices, users can logon to the Company�� Website at www.pocketfinder.com or use its native iPhone, iPad or Android Apps.

The Company�� products are sold through various brick-and-mortar and online retailers and through its Website. It provides customer service and support in the United States through existing call centers owned by Affinitas. It provides wireless location based solutions for global positioning products along with its friendly user interface software system. PocketFinder and PocketFinder Vehicle devices are being sold in the United States and in Canada through the Apple Online Store and Apple Retail Stores. PocketFinder devices for Pets are available for purchase on its Website.

The Company competes with Geospatial Platform Providers, Application Developers, Garmin�� GTU-10, Qualcomm�� Tagg, Lo-Jack, SpotLight, Fleetmatics, NetworkFleet, and Qualcomm.

Advisors' Opinion:

• [By CRWE]

  Today, LBAS has shed (-7.69%) -0.010 at $.120 with 95,100 shares in play thus far (ref. google finance Delayed: 12:21PM EDT August 15, 2013).

  Location Based Technologies, Inc. previously reported it has signed a distribution agreement with Beijing Lava Technology Co. Ltd., an Apple approved distributor for its online, brick and mortar stores, and authorized distributors in Asia. The agreement is one of the final steps preceding the launch of LBT�� GPS products into the Asian markets. Beijing Lava Technology Co. Ltd. serves China, Singapore, Japan, Korea, Taiwan, Malaysia, and Indonesia.

  LBT estimates that it will begin selling its PocketFinder devices in Singapore through Apple�� online store and authorized distributors in the near future with other Asian countries to follow thereafter.

• [By CRWE]

  Today, LBAS�remains (0.00%) +0.000 at $.132 with 9,470 shares in movement thus far (ref. google finance Delayed: 9:47AM EDT June 20, 2013).

  Location Based Technologies, Inc. previously received FCC and IC certification for its versatile LBT-886 device. These certifications are necessary before devices can be sold to consumers throughout the US and Canada.

  The LBT-886 device is available for manufacture in a 2G or 3G variant. The 3G penta-band variant will enable the device to function in countries which only operate on the 3G spectrum, such as Australia, South Korea, Japan and some areas of Canada. This global tracking solution also delivers additional features such as various environmental sensors or comes with an attachment with special capability designed to meet lone-worker or personnel security requirements

• [By CRWE]

  Today, LBAS surged (+10.27%) up +0.015 at $.160 with�39,780 shares in play thus far (ref. google finance Delayed: 11:41AM EDT July 5, 2013).

  Location Based Technologies, Inc. and EE, Ltd., the U.K.�� most advanced communications company, have previously entered into a purchase agreement which will allow LBT to embed EE SIM technology into LBT�� world�� best GPS products for immediate purchase throughout Europe and in additional areas around the world.

  EE�� relationship with LBT continues to grow. The companies began their relationship earlier this year when EE launched PocketFinder Personal GPS Locators in their London flagship stores (https://explore.ee.co.uk/pocket-finder). With this latest agreement, LBT now has the capability to sell devices into Europe using a local SIM, thereby greatly reducing the monthly service fee charged to customers.

Best Communications Equipment Stocks To Watch Right Now: LifeLock Inc (LOCK)

LifeLock, Inc., incorporated on April 12, 2005, is a provider of proactive identity theft protection services for consumers and identity risk assessment and fraud protection services for enterprises. It operates in two segments: consumer segment and an enterprise segment. In its consumer segment, the Company offer identity theft protection services to consumers on a monthly or annual subscription basis. In its enterprise segment, it offer identity risk assessment and fraud protection services to enterprise customers who pay the Company based on their monthly volume of transactions with it. It protects its consumer subscribers, whom it refers to as its members, by monitoring identity-related events, such as new account openings and credit-related applications. It also provides remediation services to its members in the event that an identity theft actually occurs. On March 14, 2012, the Company acquired ID Analytics, Inc. In December 2013, the Company announced that it has completed the acquisition of Lemon Inc.

Consumer Business

The Company protects its members by proactively monitoring identity-related events, such as new account openings and credit-related applications, which may present a risk of identity theft. If it detects that a member�� personally identifiable information is being used, the Company sends notifications and alerts, including proactive, near real-time, actionable alerts, to the member via text message, phone call, or e-mail through its LifeLock Identity Alert system that allows the member to confirm valid or unauthorized identity use.

Enterprise Business

The Company delivers on-demand identity risk assessment and authentication information about consumers to its enterprise customers in their daily transaction flows. Its enterprise customers utilize this information in real time to authenticate their customers, assess their risk profile, and enhance the enterprise�� decision making process on which to base account opening, le! nding, credit, and other risk-based decisions. By integrating its services into their business processes, its enterprise customers can reduce potential financial losses from identity fraud. Information generated from the transaction flow at its enterprise customers is transmitted back to its data repositories, which continually enhances the LifeLock ecosystem and helps strengthen the services the Company can provide to its customers in the future.

The Company competes with Experian, Equifax, TransUnion, Affinion, Early Warning Systems, Intersections and LexisNexis.

Advisors' Opinion:

• [By Rick Aristotle Munarriz]

  AFP/Getty Images/Gabriel Bouys Companies can make brilliant moves, but there are also times when things don't work out quite as planned. From a luxury electric car maker ramping up its production to sandwich makers failing to make dough rise, here's a rundown of the week's smartest moves and biggest blunders in the business world. Tesla Motors (TSLA) -- Winner The Model S isn't cheap, but Tesla is selling enough of them to impress investors. Shares of the maker of plug-in electric vehicles raced to a new high after announcing that it delivered 6,892 cars in its latest quarter. Things will get even better in 2014 as Tesla expects to sell and deliver 35,000 vehicles. Tesla will need to ramp up its production -- currently, roughly 600 cars a week -- to closer to 1,000 Model S and new Model X cars by the end of the year. Conn's (CONN) -- Loser It isn't easy running a consumer electronics store these days. Shares of Conn's plunged 43 percent on Thursday after warning that its holiday quarter results will fall well short of its earlier expectations. If that seems like a significant drop for a mere miss, let's dive a little deeper. Conn's also warned that it's suffering from higher loan delinquencies than usual. Conn's provides in-house consumer credit on its appliances, furniture, mattresses, and consumer electronics, so revealing that 8.8 percent of its loan portfolio hasn't made a payment in more than 60 days is problematic. Conn's, which has stores in the Southwest, blames cold weather for disrupting payments, but things are never as simple as that. Conn's was holding up better than its peers that had imploded earlier this year on reports that the holidays weren't so jolly this time around. Now we know that Conn's is merely mortal, and that way too many of its customers last year aren't current on their payments. Candy Crush Saga -- Winner The company behind "Candy Crush Saga" filed to go public this week. Dublin-based King Digital Entertainment is hoping

Best Communications Equipment Stocks To Watch Right Now: Revolution Lighting Technologies Inc (RVLT)

Revolution Lighting Technologies Inc., incorporated on December 16, 1993, designs, manufacture, market and sells commercial grade, light emitting diode (LED) replacement light bulbs and LED-based signage, channel letter and contour lighting products. The Company sells these products under the Seesmart, Array Lighting and Lumificient brand names. The Company operates in two segments: LED replacement lamps and fixtures and LED signage and lighting strips. On December 20, 2012, the Company acquired Seesmart Technologies, Inc., headquartered in Simi Valley, California. In August 2013, the Company announced that it has completed the acquisition of Relume Technologies (Relume). In October 2013, the Company announced that it has acquired a portfolio of general illumination LED lighting products, including several product lines from CMG Energy Solutions (CMG). In November 2013, the Company acquired Tri-State LED.

The Company�� LED replacement lamps and fixtures segment include the Seesmart business and the Array business, which has been integrated with the Seesmart business. The LED signage and lighting strips segment is comprised of the Lumificient business.

Advisors' Opinion:

• [By Stock Investor]

  First up we have Revolution Lighting Technologies, Inc (RVLT). As of last week RVLT had a market cap of $280m. Revenues for the last year came in at $4.4m. The company is averaging a cash burn of approximately $7m per quarter over the last two quarters. If I give the company the benefit of the doubt and assume the $7.5m of investments they made last quarter was a one time event, the cash burn then drops to under $4m per quarter. In March RVLT raised $5m from the issuance of shares priced at $1.17. The company is still in need of additional financing, and with the stock price up 400% in the last three months, it would be wise for them to issue shares right now. This increases the risk for investors dramatically right now.

• [By Paul Ausick]

  Big Earnings Movers: The Walt Disney Co. (NYSE: DIS) is up 2.1% at $68.58 on a good showing for its films but not so much for its TV programming. Molycorp Inc. (NYSE: MCP) is up 1.8% at $4.85 after offering a weakish outlook. Revolution Lighting Technologies Inc. (NASDAQ: RVLT) is up 21.5% at $3.28 after a strong report and reaffirmed solid outlook.

• [By Paul Ausick]

  Without making too much fuss over a small-cap stock, Revolution Lighting Technologies Inc. (NASDAQ: RVLT) is seeing its share price rise by nearly 25% today after reporting results this Friday morning. Yahoo! Finance does not have any estimates for the company, but Revolution posted an operating loss of $3.1 million in the quarter, more than four times worse than its loss in the same period in 2012. Even with adjustments Revolution�� operating loss totaled $1.8 million.

Best Communications Equipment Stocks To Watch Right Now: TomTom NV (TMOAF.PK)

TomTom NV is the Netherlands-based supplier of location and navigation products and services. The Company�� offer includes maps, speed cameras, portable navigation devices (PND), fleet management services (FMS), and smart phone applications. It consists of four customer-facing segments: Consumer, Automotive, Business Solutions and Licensing. The Consumer segment is engaged in the sale of PNDs, speed cameras, maps and other related navigation services to end customers. Automotive sells in-dash navigation solutions, speed cameras, grade maps and services to companies in automotive segment, as well as PNDs for fitness products. The Business solutions segment provides fleet management services and solutions, such as fleet trackers, to fleet owners. Licensing sells digital maps, mobile applications and other content to customers within multiple market segments. The Company operates in over 35 countries worldwide. In July 2013, it acquired Coordina (Gestion Electronica Logistica, S.L.). Advisors' Opinion:

• [By Genesis Housing]

  Nokia's HERE division is worth E1bn assuming a similar market cap as TomTom (TMOAF.PK) but offers significant upside as maps become the next platform for e-commerce. Assuming Nokia's net cash position declines to E2bn at Q3 from E4.1bn in Q2 (given the E1.7bn NSN deal as well as incremental cash burn due to supporting product launches), the combined value of Nokia's Net Cash, HERE division and NSN division is in line with the current market cap of Nokia.

Best Communications Equipment Stocks To Watch Right Now: PositiveID Corp (PSID)

PositiveID Corporation (PositiveID), incorporated in November 2001, is engaged in developing, marketing and selling radio frequency identification (RFID), systems used for the identification of people in the healthcare market. PositiveID is focused on providing health and security identification tools to protect consumers and businesses, operating in two segments: HealthID and ID Security. The Company�� HealthID segment is focused on the development of four products, which includes the GlucoChip, iglucose, Easy Check and the rapid flu detection system. Its ID Security segment includes the identity security suite of products, sold through its NationalCreditReport.com brand and its Health Link personal health record (PHR) business. In July 2011, it completed the sale of substantially all of the assets of NationalCreditReport.com. On May 23, 2011, the Company acquired all of the interest of MicroFluidic Systems (MicroFluidic). In November 2013, the Company sold its interest in VeriTeQ Corporation (VeriTeQ).

HealthID Segment

PositiveID�� HealthID segment product GlucoChip is a glucose-sensing microchip is developed in conjunction with Receptors LLC (Receptors). Iglucose is a self-contained unit that automatically queries a diabetic user�� data-capable glucometer for blood glucose data and sends that data via encrypted text messaging to the iglucose online database. Easy Check is a non-invasive breath glucose detection system, based on the correlation of acetone in exhaled breath to blood glucose levels. The rapid flu detection system is also developed in conjunction with Receptors. The Company�� HealthID segment also includes the VeriMed system, which uses an implantable passive RFID microchip (the VeriChip) that is used in patient identification applications. Each implantable microchip contains a verification number that is read when it is scanned by its scanner.

ID Security Segment

PositiveID�� NationalCreditReport.com business offers consu! mers a range of identity security products and services primarily on a subscription basis. These services help consumers protect themselves against identity theft or fraud and understand and monitor their credit profiles and other personal information, which include credit reports, credit monitoring and credit scores. The Company has Health Link PHR business.

Healthcare Products

PositiveID�� Healthcare products include the GlucoChip, a product that combines a glucose-sensing microtransponder. The Company has partnered with Receptors to develop an in-vivo glucose sensor to detect glucose levels in the human body. In conjunction with Receptors, the Company has completed Phase I and Phase II development of the glucose-sensing microchip and are in Phase III development. The Easy Check breath glucose test, as of January 31, 2012 is under development, is a non-invasive glucose detection system that measures acetone levels in a patient�� exhaled breath. The iglucose system uses machine to machine technology to automatically communicate a diabetic�� glucose readings to the iglucose online database.

MicroFluidic Systems

MicroFluidic specializes in the production of automated instruments for a range of applications in the detection and processing of biological samples, ranging from rapid medical testing to airborne pathogen detection for homeland security. MicroFluidic�� substantial portfolio of related to sample preparation and rapid medical testing applications are the portfolio of virus detection and diabetes management products.

Identity Security Products and Services

National Credit Report.com, LLC (NCRC) is engaged in the consumer provision of credit reports, credit score and credit monitoring products. This business provides a medium for consumers to retrieve and review their credit history, as well as monitor their credit files with one or all three of the major credit reporting bureaus: Experian, Equifax and TransUni! on. The C! ompany�� products and services are offered to consumers on a monthly subscription basis.

Health Link Personal Health Record and Other Applications

Health Link is a patient-controlled, online repository to store personal health information, such as medications, allergies, family history, previous surgeries, vaccinations and lab results. Health Link also connects the patient to a multitude of customized materials, such as personalized health education and online connectivity to caregivers. Patients can also utilize Health Link to connect with numerous Electronic Medical Record (EMR) systems that are accessible through Microsoft HealthVault and Google Health. In conjunction with Raytheon Microelectronics Espana, the Company developed an eight millimetre microchip, which has functionality that is substantially equivalent to the VeriChip.

Advisors' Opinion:

• [By James E. Brumley]

  Ever heard of PositiveID Corp. (OTCMKTS:PSID)? Most people haven't, so don't worry if it's an unfamiliar name. What's surprising is that PSID is still a little unfamiliar to the masses at this stage of the Ebola game. It's not just a worry that we only have to worry about domestically. It's now spreading within the United States, which is a whole different ball game than preventing it from getting to the United States. This presents a real risk of pandemic spreading within our borders. PositiveID can help.

Best Communications Equipment Stocks To Watch Right Now: WiLan Inc (WILN)

WiLAN Inc. (WiLAN), incorporated on May 14, 1992, is a licensing company. WiLAN develops, acquires, and licenses a range of intellectual property that drives products in communications and consumer electronics markets. Through both internal research and development and acquisitions from third parties, the Company has acquired intellectual property in the form of patents and patent applications in many countries that it has licensed to more than 255 companies in telecommunications markets around the world. As of December 31, 2011, WiLAN had a portfolio of approximately 3,000 patents, including issued and pending patents and foreign equivalents. WiLAN has five directly wholly-owned subsidiaries, Wi-LAN Capital Inc. (WiLAN Capital), Wi-LAN International Inc. (WiLAN International), Wi-LAN International Hong Kong Inc. (WiLAN Hong Kong), Wi-LAN International Japan Inc. (WiLAN Japan) and Wi-LAN International Taiwan Inc. In July 2012, it acquired a global portfolio of more than 40 patents and applications from Siemens AG related to telecommunication network management and mobile multimedia. In October 2012, the Company acquired a global portfolio of more than 150 patents and patent applications from Alvarion Ltd. In June 2013, WiLan Inc acquired a portfolio of patents from Cypress Semiconductor Corporation. In November 2013, the Company acquired a portfolio of semiconductor patents from IXYS CH GmbH related to microcontroller technology.

In the Company's licensing business, the Company has signed licenses with companies that sell products utilizing technologies, including CDMA (Code Division Multiple Access-a cellular telecommunications specification); Wi-Fi (the underlying technology of wireless local area networks based on various IEEE 802.11 specifications); WiMAX (Worldwide Interoperability for Microwave Access-a standards-based broadband wireless technology that provides metropolitan area network connectivity based on IEEE 802.16 specifications); LTE (Long Term Evolution-high performance air! interface for cellular mobile communication systems designed to increase the capacity and speed of mobile telephone networks), and ADSL (Asymmetric Digital Subscriber Line-a standards-based access technology that provides broadband Internet access over twisted pair telecommunications wiring). The Company has also signed licenses with companies that sell products utilizing technologies, including DOCSIS (Data Over Cable Service Interface Specifications-a standards-based access technology that provides broadband Internet access over cable networks); Bluetooth (a wireless protocol for exchanging data over short distances between fixed and mobile devices), and V-Chip (a technology that permits the blocking of television programs at a receiver (such as a television, multi-media equipped personal computer or set-top box) by viewers based on ratings information carried on the television signal).

Advisors' Opinion:

• [By Rich Duprey]

  Often accused of being a patent troll,�non-performing entity�WiLAN� (NASDAQ: WILN  ) wrangled a settlement out of Dell (NASDAQ: DELL  ) with details of the deal remaining confidential.

• [By Monica Gerson]

  Breaking news

  Wi-LAN (NASDAQ: WILN) today announced that its Board of Directors has initiated a process to explore and evaluate a broad range of strategic alternatives for the Company to enhance shareholder value. To read the full news, click here. MannKind (NASDAQ: MNKD) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of a New Drug Application (NDA) for AFREZZA庐 (insulin human [rDNA origin]) Inhalation Powder. To read the full news, click here. lululemon athletica (NASDAQ: LULU) today announced that Tara Poseley has been appointed to its Senior Leadership Team as Chief Product Officer. To read the full news, click here. Nice Systems (NASDAQ: NICE) reported a drop in its third-quarter profit. To read the full news, click here.

  Posted-In: Bank of America FOMC US Stock FuturesNews Eurozone Futures Pre-Market Outlook Markets

Best Communications Equipment Stocks To Watch Right Now: Juniper Networks Inc (JNPR)

Juniper Networks, Inc. (Juniper Networks), incorporated on September 10, 1996, designs, develops, and sells products and services that together provide its customers with network infrastructure. It operates in two segments: Infrastructure and Service Layer Technologies (SLT). The Company�� Infrastructure segment primarily offers routing and switching products that are used to control and direct network traffic from the core, through the edge, aggregation, and the customer premise equipment level. Infrastructure products include its Internet protocol (IP) routing, carrier Ethernet routing portfolio, and Ethernet switching portfolio. In addition, the Infrastructure segment offers a complete wireless local area network (WLAN) solution. Its SLT segment offers solutions that meet a range of its customers' priorities, from protecting the users, applications and data on the network itself to providing network services across a distributed infrastructure. Effective September 13, 2013, Juniper Networks, Inc. acquired Contrail Networks Inc.

Brilliant is a supplier of packet-based, network synchronization equipment and monitoring solutions. During the year ended December 31, 2011, the Company introduced its network architecture and fabric technology for the data center, QFabric. It serves the high-performance networking requirements of global service providers, enterprises, and public sector organizations. The Company�� open cross-network software platform includes the Junos operating system (Junos OS), Junos Space network application platform, and Junos Pulse integrated network client. The Company offers a product portfolio that spans routing, switching, security, application access, and mobility device security.

Infrastructure Products

The Company�� T Series core routers are primarily designed for core IP infrastructures and are also being sold into the multi-service environment. Its PTX Series is a large capacity (8 and 16 tera-bits per second) MPLS-optimized packe! t transport switch for the core networks, of content service providers and Tier 1 service providers, with high throughout of packet traffic. The Company�� E Series products are a full featured platform designed for the network edge with support for carrier-class routing, broadband subscriber management services, and a set of IP services. The MX Series is a product family developed to address emerging Ethernet network architectures and services in service provider and enterprise networks. The Company�� EX Series family extends its product portfolio running its Junos OS to address the Ethernet switch market. Ethernet is a used technology, which is used to transport information in enterprise networks. Infrastructure Products also includes QFabric Products and WLAN product.

SLT Products

SLT Products include Services Gateway, Integrated Firewall, and VPN Solutions, Secure Access Appliances, Secure Access Appliances, IDP Series Appliances and Identity and Policy Control Solutions. The Company�� SRX Series of dynamic services gateways, running its Junos software, provides firewall/VPN and combines routing, switching, and security functionality. The series is designed to meet network and security requirements for data center consolidation, rapid managed services deployments, and aggregation of security services. Its firewall and VPN systems and appliances are designed to provide integrated firewall, VPN, and denial of service protection capabilities for both enterprise environments and service provider network infrastructures. These products range from its SSG product series, which combines LAN/WAN routing capabilities with threat management features, such as antivirus, anti-spam, and Web filtering technologies, to its ISG and NetScreen Series firewall and VPN systems, which are designed to deliver security in medium/large enterprises, carrier networks, and data centers.

The Company�� Junos Pulse, Junos Pulse Mobile Security Suite, and SA Series SSL VPN appliances,! designed! for use in companies of all sizes, are used to provide secure access to corporate resources for remote and mobile users from any Web-enabled device, regardless of location. Its portfolio of identity and policy control solutions integrates subscriber privileges, application requirements, and business policies with the IP network infrastructure.

The Company competes with Cisco Systems, Inc. (Cisco), Alcatel-Lucent, Brocade Communications Systems, Inc. (Brocade), Extreme Networks, Inc., Hewlett Packard Company (HP), Huawei Technologies Co., Ltd. (Huawei), Check Point Software Technologies, F5 Networks, Inc., Palo Alto Networks, Inc., and Riverbed Technology, Inc.

Advisors' Opinion:

• [By Monica Wolfe]

  The following information is a highlight of the real-time guru activity we saw this week. To view more information on these gurus, check out their guru portfolios. The ��eal Time Picks��reports the stock purchases and sells that Gurus have made within the prior two weeks. If a Guru makes a purchase or sell of a company in which they own a greater-than 5% stake, SEC regulations require them to report their transaction within two days. This week we saw notable increases and buys in Real Time activity from Kyle Bass (Trades, Portfolio) and Paul Singer (Trades, Portfolio).Kyle Bass (Trades, Portfolio) Over the past week Kyle Bass (Trades, Portfolio) made a notable increase in to Nationstar Mortgage Holdings (NSM). The guru added a total of 3,673,972 shares of the company�� stock. He bought these shares at an average price of $31.27 per share, and since then the price per share has gone up about 5% to $32.80 per share.Bass now holds on to 4,759,610 shares of Nationstar Mortgage holdings, representing 5.26% of the company�� shares outstanding.Bass�� historical holding history as of the close of the fourth quarter 2013:Nationstar Mortgage provides residential mortgage loan services. It services residential mortgage loans throughout the United States. Nationstar is one of the largest servicers in the US, with a residential mortgage servicing portfolio of over $391 billion in unpaid principal balance as of Dec. 31, 2013.Nationstar Mortgage�� historical revenue and net income:The company recently released its fourth quarter and full year financial results which highlighted:- 2013 GAAP EPS of $2.40 on net income of $217 million.- Ending servicing portfolio UPB of $391 billion.- 2013 servicing portfolio growth of 88%.- 2013 return on equity of 25%.- Funded volume of $24 billion in 2013.The company also recently announced that they had received a letter from Benjamin Lawsky, Superintendent of the New York Department of Financial Services, which inquires about Nat

Top 10 Biotech Companies To Buy For 2015

In the health care sector, investors can tap into the full range of the risk spectrum. They can swing for the fences with bets on emerging biotechnology companies set to deliver groundbreaking new drugs, or they can make lower risk plays on “Big Pharma,” hoping these giant drug makers can stay ahead of their patent expiration curve.

Among the lowest risk plays of all in the sector are distribution companies that produce steady growth and returns on trends as simple as increasing utilization.

Henry Schein (NSDQ: HSIC) is a global distributor of health care products, including medical, dental and animal health care supplies with about 35 percent of sales outside of the US. It also offers software systems used to manage finances, educational requirements and other office functions as well as value-added services such as practice design.

Since the company went public in 1995, its sales have grown at an annual compound rate of 17 percent, rising from $616.2 million to $8.9 billion last year. Earnings per share (EPS) have experienced similar growth, up from $0.34 in 1995 to $4.44 in 2012.

Top Financial Companies To Own For 2016: Regeneron Pharmaceuticals Inc.(REGN)

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. The company?s commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the treatment of cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome in adults and children. Its products under Phase III clinical development stage consist of VEGF Trap-Eye, an aflibercept ophthalmic solution developed using intraocular delivery for the treatment of serious eye diseases; ARCALYST for the prevention of gout flares in patients initiating uric acid-lowering treatment; and Aflibercept (VEGF Trap), which is developed in oncology. The company?s earlier stage clinical programs include various human antibodies, such as REGN727 for low-density lipoprotein cholesterol reduction, REGN88 for rheumatoid arthritis and ankylosing spondylitis; REGN668 for atopic dermatitis and asthma; REGN421 and REGN910 for oncology; REGN475 for the treatment of pain; and REGN728 and REGN846. It also conducts preclinical research programs in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, and infectious diseases. The company distributes its products through third party service providers. It has strategic collaboration with sanofi-aventis Group to discover, develop, and commercialize human monoclonal antibodies; and Bayer HealthCare LLC to develop and commercialize VEGF Trap. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is based in Tarrytown, New York.

Advisors' Opinion:

• [By Traders Reserve]

  Regeneron (REGN) shares could see a big jump in 2014. The big promise in the year is with respect to expansion of its eye treatment product, Eylea. Analysts expect the company to grow profits by more than 50% in 2014. At current prices shares trade for 54 times 2014 estimated earnings. That�� a rich premium, but not nosebleed compared to some momentum stocks. The real potential for growth to be even larger than expected is what turns on the momentum ground and as other rocket ships come back to earth look for this one to keep on climbing.

Top 10 Biotech Companies To Buy For 2015: Vertex Pharmaceuticals Incorporated(VRTX)

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for the treatment of serious diseases worldwide. Its products include telaprevir, a prescription medicine used for the treatment of patients with genotype 1 hepatitis C virus (HCV) infection; and Ivacaftor, a prescription medicine used for the treatment of cystic fibrosis. The company markets its products under the INCIVEK brand name in the United States and Canada; INCIVO brand in the United Kingdom, Germany, France, Sweden, Austria, Finland, Denmark, Switzerland, and Norway; KALYDECO brand in the United States; and TELAVIC brand in Japan. Its drug candidates comprise VX-222, a Phase II clinical trial drug candidate, and ALS-2200 and ALS-2158, a Phase I clinical trial drug candidates that are designed to inhibit the replication of HCV; VX-809 and VX-661, a Phase II clinical trial drug candidates that improve the function of defective cystic fibro sis; VX-509, a Phase II clinical trial drug candidate for the treatment of patients with rheumatoid arthritis and other immune-mediated inflammatory diseases; VX-765, a Phase II clinical trial drug for the treatment of epilepsy; and VX-787, an investigational drug candidate for the treatment of influenza A. The company was founded in 1989 and is headquartered in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Ben Levisohn]

  Sovaldi selling way beyond our expectations. The initial prescription data are so massively outperforming even the biggest weeks Incivek ever had, we believe any reasonable comparison between the two drugs would indicate that U.S. sales in 2014, alone, are going to exceed $5 billion. In 4Q11, Vertex (VRTX) recognized $458 million in Incivek sales and WK reported 11,409 NRx. Sovaldi is already pacing more than 2x that volume in 1Q14. Sovaldi also has ~70% price premium over Incivek. There is almost no way barring an extreme reduction in volume over the next few weeks that Gilead won’t hit at least $1 billion in sales in 1Q14 (consensus is at $336 million), and that really only accounts for U.S. sales. While we expect a slower uptake ex-US, we note that historical Incivo sales indicate that there is likely to be an additional $1 billion in Sovaldi sales in 2014 coming from ex-U.S. territories. We believe this volume implies that next year’s sofosbuvir/ledipisvir sales are not only set to be the best launch ever, but exceed the highest single year sales of any pharmaceutical product in history…As a result of our model changes, we are raising our price target to $103 and elevating the stock to Outperform.

• [By Northwest Trader]

  That was the case until Vertex's (VRTX) successful launch of VX-770 (Kalydeco) in January of 2012.

  Kalydeco (Ivacaftor) addresses the G551D mutation via CFTR modulation (potentiator), and is an orphan drug with a steep price tag of $294,000 per year. As CF is a chronic disease, this represents a potential gross revenue of roughly 340 million dollars per year.

• [By Garrett Cook]

  Vertex Pharmaceuticals (NASDAQ: VRTX) shares shot up 42.73 percent to $95.07 after the company reported that its two phase 3 studies of Lumacaftor in combination with ivacaftor met the primary endpoint.

• [By Sean Williams]

  Vertex Pharmaceuticals (NASDAQ: VRTX  ) suffered through an unpleasant week, with shares down 9% after it announced a partial clinical hold on Friday for its all-oral hepatitis-C drug, VX-135. The drug, which is currently in midstage trials, was placed on clinical hold by the FDA after it noted elevated, but reversible, liver enzyme levels in patients receiving the 400mg dose with ribavirin. To me this looks like a precautionary hold, but it will be perceived as painful, since it puts Vertex's oral hepatitis-C medication that much further behind its competition. Kalydeco is becoming the future of Vertex with regard to its potential to treat various mutations of cystic fibrosis, so I wouldn't worry too much about this minor setback with VX-135.

Top 10 Biotech Companies To Buy For 2015: Flexion Therapeutics Inc (FLXN)

Flexion Therapeutics, Inc. (Flexion Therapeutics), incorporated on November 5, 2007, is a pharmaceutical company focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, a type of degenerative arthritis, referred to as OA. The Company�� portfolio of small molecule product candidates addresses the OA pain treatment spectrum, from moderate to severe pain. The Company�� product candidate, FX006, is an injectable intra-articular, meaning in the joint, sustained-release treatment for patients with moderate to severe OA pain. It is developing two additional product candidates, FX007 for post-operative pain and FX005 to treat end-stage OA patients. FX007 is a locally administered TrkA receptor antagonist for persistent relief of post-operative pain, including in patients who have received total joint replacement, also referred to as total joint arthroplasty (TJA). Its product candidates are designed to deliver established anti-inflammatory and analgesic effects directly to the site of disease, optimizing sustained local drug concentration to achieve a durable and clinically meaningful response. These product candidates are also designed to limit systemic exposure to the drugs and minimize systemic toxicities.

FX006 - Front Line IA Therapy for Patients with Moderate to Severe OA Pain

FX006 is a steroid, triamcinolone acetonide (TCA), formulated for sustained-release, delivered through intra-articular (IA) injection and designed to treat moderate to severe OA pain. FX006 combines commonly administered TCA with poly lactic-co-glycolic acid (PLGA), its injectable IA sustained-release technology. As of January 8, 2014, two clinical trials had been conducted to test FX006 against immediate-release TCA injection. FX006 has been studied in two clinical trials, in which a total of 196 patients received FX006! and a total of 56 patients received immediate-release TCA: Study FX006-2011-001 and Study FX006-2011-002.

FX007-For Post-Operative Pain

FX007 is a small molecule TrkA receptor antagonist that is in development for the persistent relief of post-operative pain. TrkA is the receptor for nerve growth factor, commonly known as NGF, a small peptide that is released following tissue injury. NGF binds to TrkA on the surface of pain sensing neurons and renders these cells more responsive to external stimuli.

FX005-For End-Stage OA Pain

FX005 is intended as therapy for patients with end-stage OA pain, particularly those patients awaiting TJA, as an alternative to opioids. FX005 is a p38 MAP, or mitogen-activated protein, kinase inhibitor formulated for sustained-release delivered through IA injection, which is designed to have both analgesic and anti-inflammatory benefits without the systemic side effects of oral p38 MAP kinase inhibitors. p38 MAP kinase is an enzyme in an inflammatory cascade that upregulates in response to stress and culminates in the elaboration of multiple proinflammatory cytokines, including interleukin 1 and tumor necrosis factor, as well as enzymes like matrix metalloproteinases that have the potential to destroy cartilage. In other studies, multiple oral p38 MAP kinase inhibitors have been evaluated in inflammatory diseases and pain and, while efficacy has been demonstrated, serious toxicity affecting multiple organ systems has been frequently observed. FX005 has completed a Phase-II A clinical trial, in which 70 patients were randomized to FX005 and 70 patients were randomized to placebo.

The Company competes with Fidia Farmaceutici S.p.A, Ampio Pharmaceuticals, Inc., Carbylan BioSurgery, Inc., Merck Serono and Allergan, Inc., Pacira Pharmaceuticals, Janssen Pharmaceuticals, Inc. and Johnson & Johnson.

Advisors' Opinion:

• [By John Udovich]

  It�� a new year and the first one and a half trading weeks of 2014 has not disappointed biotech investors as the sector and mid cap or small cap biotech or�pharma stocks like Intercept Pharmaceuticals Inc (NASDAQ: ICPT), Epizyme Inc (NASDAQ: EPZM), Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) and TNI BioTech Inc (OTCQB: TNIB) either surging or producing some news plus there have been IPO filings for future listings for�Flexion Therapeutics (NASDAQ: FLXN), Aldexa Therapeutics (NASDAQ: ALDX), Retrophin (NASDAQ:�RTRX) and Dicerna Pharmaceuticals (NASDAQ: DRNA). Consider the following news so far this year:

• [By John Udovich]

  The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:

Top 10 Biotech Companies To Buy For 2015: Osiris Therapeutics Inc.(OSIR)

Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing of therapeutic products to treat various medical conditions in the inflammatory, autoimmune, orthopedic, and cardiovascular areas. It operates in two business segments, Therapeutics and Biosurgery. The Therapeutics segment focuses on developing biologic stem cell drug candidates from a readily available and non-controversial source, adult bone marrow. The Biosurgery segment works to harness the ability of cells and novel constructs to promote the body's natural healing. This segment focuses on developing biologic products for use in surgical procedures. The company?s lead biologic drug candidate is Prochymal, which is in phase 2 and 3 clinical trails for various indications, including acute graft versus host disease (GvHD), Crohn's disease, acute myocardial infarction, type 1 diabetes, pulmonary disease, and gastrointestinal injury resulting from radiation exposure. Its biologic drug candidates also include Chondrogen, a preparation of adult mesenchymal stem cells that is in phase 2 clinical trials for osteoarthritis and cartilage protection. The company has collaboration agreements with Genzyme Corporation for the development and commercialization of Prochymal and Chondrogen in various countries except in the United States and Canada. It also has a partnership with Juvenile Diabetes Research Foundation for the development of Prochymal as a treatment for the preservation of insulin production in patients with newly diagnosed type 1 diabetes mellitus. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

Advisors' Opinion:

• [By Alexander Maxwell]

  One of the companies attempting to develop a better treatment for chronic diabetic foot ulcers is Osiris Therapeutics� (NASDAQ: OSIR  ) . Earlier this month, Osiris shares more than doubled as the company announced positive data for its CDFU drug Grafix. The study results were very impressive to say the least; the study was stopped early due to the overwhelming efficacy exhibited by the treatment. A main highlight is the fact that 62% of Grafix patients had their wound closed at 12 weeks, compared to only 21% of patients using conventional methods. Clearly, the efficacy in this endpoint was overwhelming. Grafix also achieved all of the secondary endpoints for the trial, and more importantly demonstrated a relatively benign safety record.�

• [By Lauren Pollock]

  Osiris Therapeutics Inc.(OSIR) said Friday a proposed ruling from the Centers for Medicare and Medicaid Services won’t immediately affect reimbursements for its Grafix stem-cell product. The regenerative medicine company said Grafix will maintain its current reimbursement status — also called transitional pass-through status — potentially through late 2015.

• [By Maxx Chatsko]

  Additionally, stem cell therapies have remained elusive as the industry's ultimate Holy Grail. Osiris (NASDAQ: OSIR  ) received Canadian approval for the world's first stem cell drug, Prochymal, for children battling acute graft-versus-host disease, or GvHD, last year. The approval meant more symbolically than to the bottom line, but it definitely put the potential of stem cells front and center for investors.

Top 10 Biotech Companies To Buy For 2015: ArQule Inc.(ARQL)

ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development of cancer therapeutics directed toward molecular targets and biological processes. Its lead product ARQ 197 is non-adenosine triphosphate competitive inhibitor of the c-Met receptor tyrosine kinase, which is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in non-small cell lung cancer, c-Met-associated soft tissue sarcomas, pancreatic adenocarcinoma, hepatocellular carcinoma, germ cell tumors, and colorectal cancer. The company is also developing ARQ 621, a Phase I program focused on inhibition of the Eg5 kinesin spindle protein. Its clinical stage products include ARQ 501, ARQ 761, and ARQ 171, which are designed to kill cancer cells selectively while sparing normal cells through the direct activation of DNA damage response/checkpoint pathways. In addition, the company involves in pre-clinical development o f B-RAF and AKIP Kinase inhibitors. The company has collaborations with Kyowa Hakko Kirin Co., Ltd. and Daiichi Sankyo Co., Ltd. ArQule, Inc. was founded in 1993 and is headquartered in Woburn, Massachusetts.

Advisors' Opinion:

• [By Roberto Pedone]

   

  ArQule (ARQL), a clinical-stage biotechnology company, researches and develops cancer therapeutics. This stock closed up 3.4% to $1.49 in Thursday's trading session.

   

  Thursday's Range: $1.44-$1.54
  
  52-Week Range: $1.29-$2.94
  
  Thursday's Volume: 908,000
  
  Three-Month Average Volume: 567,811

   

  From a technical perspective, ARQL jumped higher here right above some near-term support at $1.40 with above-average volume. This move briefly pushed shares of ARQL back above its 50-day moving average of $1.53, before the stock closed just below that level at $1.49. This move is starting to push shares of ARQL within range of triggering a near-term breakout trade. That trade will hit if ARQL manages to take out some near-term overhead resistance levels at $1.54 to $1.60 with high volume.

   

  Traders should now look for long-biased trades in ARQL as long as it's trending above some near-term support levels at $1.40 or at $1.35 and then once it sustains a move or close above those breakout levels with volume that hits near or above 567,811 shares. If that breakout hits soon, then ARQL will set up to re-test or possibly take out its next major overhead resistance levels at $1.66 to $1.78, or even $1.90 to $2.

   

Top 10 Biotech Companies To Buy For 2015: Celsion Corporation(CLSN)

Celsion Corporation, an oncology drug development company, develops and commercializes targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company is developing its lead product, ThermoDox that is in Phase III clinical trial for primary liver cancer; and in phase II clinical trial for treatment of recurrent chest wall breast cancer. It has a license agreement with Yakult Honsha to commercialize and market ThermoDox for the Japanese market. The company also has a license agreement with Duke University under which it received exclusive rights to commercialize and use Duke's thermo-liposome technology. In addition, Celsion Corporation has a joint research agreement with Royal Phillips Electronics to evaluate the combination of Phillips' high intensity focused ultrasound with its ThermoDox to determine the potential of this combination to treat a range of cancers. The company was founded in 1982 and is based in Columbia, M aryland.

Advisors' Opinion:

• [By EquityOptionsGuru]

  The Prolieve Thermodilatation System was actually developed by the current management of Medifocus while employed at Celsion Corporation (NASDAQ:CLSN). The system was also jointly developed with Boston Scientific (NYSE:BSX) before being acquired by Medifocus in July 2012. Prolieve has already received FDA approval, is currently generating revenue, and is the only in office alternative to drug therapy. The system essentially uses microwave energy to treat Benign Prostatic Hyperplasia (BPH), which is a non-cancerous enlargement of the prostate gland that typically affects men over the age of 50. The Prolieve device works by compressing and heating prostatic tissue that may be blocking the flow of urine. This particular treatment option offers patients several benefits including the following:

Top 10 Biotech Companies To Buy For 2015: Conatus Pharmaceuticals Inc (CNAT)

Conatus Pharmaceuticals Inc., incorporated on July 13, 2005, is a biotechnology company focused on the development and commercialization of medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. The Company has designed a clinical program to demonstrate the therapeutic benefit of emricasan across the spectrum of fibrotic liver disease. The Company�� initial development strategy targets indications for emricasan with high unmet clinical need in orphan patient populations, such as patients with acute-on-chronic liver failure (ACLF), chronic liver failure (CLF), and patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection (HCV-POLT).

The Company has completed two placebo-controlled Phase II trials in patients with liver disease showing reductions in ALT levels that occur rapidly, within as little as one day after initiation of therapy, and are maintained throughout the treatment period. In the Company�� 204-patient Phase 2b trial, it also measured cCK18, an important biomarker of apoptosis and disease severity. Emricasan has been generally well-tolerated in all of the clinical studies. As of July 23, 2013, the Company had not generated any revenue.

Advisors' Opinion:

• [By John Udovich]

  While Intercept Pharmaceuticals Inc (NASDAQ: ICPT) surged earlier this year and Achillion Pharmaceuticals, Inc (NASDAQ: ACHN) has surged this week after Merck & Co. Inc (NYSE: MRK) agreed to purchase hepatitis stock�Idenix Pharmaceuticals Inc (NASDAQ: IDIX) at a 239% premium, it seems the herd has realized that small cap Conatus Pharmaceuticals Inc (NASDAQ: CNAT) is also a liver disease stock as shares suddenly surged 56.69% on no apparent company news. But just what is�Conatus Pharmaceuticals and is it worth taking a chance on?

• [By John Udovich]

  Recent IPO�FibroGen Inc (NASDAQ: FGEN) surged 22.96% today, reportedly after the journal Hepatology published the results of a workshop between the FDA and the American Association for the Study of Liver Disease (AASLD) which laid out criteria for a phase three study of a treatment for non-alcoholic steatohepatitis (NASH)���meaning its worth taking a closer look at the stock along with the performance of potential small cap or mid cap liver disease stock peers like Conatus Pharmaceuticals Inc (NASDAQ: CNAT), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) and Raptor Pharmaceutical Corp (NASDAQ: RPTP) which rose 24.35%, 10.98% and 2.02%, respectively. According to Investors Business Daily, NASH (the more serious version of fatty liver disease) is potentially an enormous market with about 6 million�US patients but the�lack of previous treatments had left it unclear how the FDA would measure success against the disease while FibroGen Inc doesn't yet have a NASH human trial in the works, it has said it hopes to start one for its lead candidate FG-3019 (its in mid-stage trials for pulmonary fibrosis and liver fibrosis due to hepatitis B infection).